Re: 'Cost-effectiveness of 5-hydroxytryptamin3 receptor antagonists: a retrospective comparison of ondansetron and granisetron'.
Thwaites
R
R
Parasuraman
T V
TV
Paska
W
W
D003362:Cost-Benefit Analysis; D017829:Granisetron / Q000191:economics*; D009325:Nausea / Q000139:chemically induced / Q000517:prevention & control; D017294:Ondansetron / Q000191:economics*; D016879:Salvage Therapy; D012702:Serotonin Antagonists / Q000191:economics*; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control
D017829:Granisetron; D017294:Ondansetron; D012702:Serotonin Antagonists